Filing Flows › Harvard Apparatus Regenerative Technology (HRGN) › Q2 2026 › vs Q2 2025
Harvard Apparatus Regenerative Technology (HRGN) Q2 2026 vs Q2 2025 (year over year)
Harvard Apparatus Regenerative Technology's revenue rose $97K (+31%) from $317K in Q2 2025 to $414K in Q2 2026.
Harvard Apparatus Regenerative Technology, Q2 2026: revenue $414K (+31% year over year), operating margin -408.7%, net loss $1.7M, operating cash flow −$569K. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $414K | $317K | $97K | +31% |
| Net loss | $1.7M | $1.8M | −$128K | -7% |
| Costs & expenses | $2.1M | $2.1M | −$41K | -2% |
| Operating costs | $2.1M | $2.1M | −$44K | -2% |
| Interest & other, net | $3K | −$10K | $13K | — |
| Cost of revenue | $391K | $302K | $89K | +29% |
| Research & development | $948K | $697K | $251K | +36% |
| General & admin | $751K | $1.2M | −$400K | -35% |
| Operating cash sources | $1.7M | $1.8M | −$128K | -7% |
| Depreciation | $1K | $1K | $0 | 0% |
| Share-based compensation | $223K | $537K | −$314K | -58% |
| Working capital & other | $902K | $344K | $558K | +162% |
| Cash used in operations | $569K | $941K | −$372K | -40% |
| Net loss absorbed | $1.7M | $1.8M | −$128K | -7% |
Questions
How much did Harvard Apparatus Regenerative Technology's revenue grow year over year in Q2 2026?
Harvard Apparatus Regenerative Technology's revenue rose $97K (+31%) from $317K in Q2 2025 to $414K in Q2 2026.